4//SEC Filing
Weldon Steven W 4
Accession 0001356710-20-000002
CIK 0000109657other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:24 PM ET
Size
9.5 KB
Accession
0001356710-20-000002
Insider Transaction Report
Form 4
Weldon Steven W
DirectorCFO
Transactions
- Sale
Common Stock
2020-12-18$0.30/sh−50,000$15,000→ 3,903,700 total - Sale
Common Stock
2020-12-17$0.30/sh−50,000$15,000→ 4,003,700 total - Sale
Common Stock
2020-12-16$0.30/sh−50,000$15,000→ 4,053,700 total - Sale
Common Stock
2020-12-17$0.31/sh−50,000$15,500→ 3,953,700 total
Footnotes (1)
- [F1]. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.
Documents
Issuer
GT Biopharma, Inc.
CIK 0000109657
Entity typeother
Related Parties
1- filerCIK 0001356710
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:24 PM ET
- Size
- 9.5 KB